Edwards Lifesciences Corp. (EW)

Sector:Health Care
Super Investor Stats:
Ownership count:4
Ownership rank:127
% of all portfolios:0.07%
Hold Price * :$66.41
History Portfolio Manager Activity Share change % change to portfolio
Q1  2024
David Rolfe - Wedgewood Partners Reduce 2.07% 5,201 0.09
Lee Ainslie - Maverick Capital Sell 100.00% 2,977 0.00
Q4  2023
Lee Ainslie - Maverick Capital Reduce 43.91% 2,331 0.00
Q3  2023
David Rolfe - Wedgewood Partners Reduce 38.51% 121,376 2.01
Q2  2023
Lee Ainslie - Maverick Capital Reduce 39.46% 2,815 0.01
David Rolfe - Wedgewood Partners Reduce 4.51% 14,897 0.23
Terry Smith - Fundsmith Sell 100.00% 9,979 0.00
Q1  2023
Francois Rochon - Giverny Capital Reduce 2.63% 11,198 0.06
David Rolfe - Wedgewood Partners Reduce 1.11% 3,690 0.05
Q4  2022
Lee Ainslie - Maverick Capital Reduce 74.56% 10,616 0.03
Francois Rochon - Giverny Capital Reduce 0.94% 4,023 0.02
Q3  2022
David Rolfe - Wedgewood Partners Reduce 2.66% 9,062 0.14
Q2  2022
David Rolfe - Wedgewood Partners Reduce 4.89% 17,531 0.29
Q1  2022
Francois Rochon - Giverny Capital Reduce 0.17% 671 0.00
Q4  2021
David Rolfe - Wedgewood Partners Reduce 25.28% 119,478 2.05
Q3  2021
David Rolfe - Wedgewood Partners Reduce 2.26% 10,909 0.17
Francois Rochon - Giverny Capital Reduce 0.83% 3,379 0.02
Q2  2021
David Rolfe - Wedgewood Partners Reduce 5.91% 30,352 0.46
Q1  2021
David Rolfe - Wedgewood Partners Reduce 13.63% 81,068 1.04
Q4  2020
David Rolfe - Wedgewood Partners Reduce 5.82% 36,762 0.50
Lee Ainslie - Maverick Capital Sell 100.00% 15,652 0.02
Q3  2020
Lee Ainslie - Maverick Capital Reduce 48.75% 14,889 0.02
David Rolfe - Wedgewood Partners Reduce 5.51% 36,824 0.46
Q2  2020
AKO Capital Sell 100.00% 753,568 3.00
Q1  2020
David Rolfe - Wedgewood Partners Reduce 36.59% 136,862 4.89
AKO Capital Reduce 9.04% 74,855 0.30
Francois Rochon - Giverny Capital Reduce 7.85% 10,089 0.24
Viking Global Investors Sell 100.00% 158,573 0.17
Q4  2019
Viking Global Investors Reduce 22.32% 45,575 0.05
David Rolfe - Wedgewood Partners Reduce 21.87% 104,727 2.48
Q3  2019
David Rolfe - Wedgewood Partners Reduce 7.98% 41,504 0.81
Q2  2019
David Rolfe - Wedgewood Partners Reduce 21.27% 140,526 2.20
Q1  2019
David Rolfe - Wedgewood Partners Reduce 19.52% 160,313 2.24
Q4  2018
Francois Rochon - Giverny Capital Reduce 32.38% 58,512 1.18
Lee Ainslie - Maverick Capital Sell 100.00% 39,160 0.08
Q3  2018
Lee Ainslie - Maverick Capital Reduce 61.55% 62,680 0.13
David Rolfe - Wedgewood Partners Reduce 8.13% 72,450 0.63
Q2  2018
David Rolfe - Wedgewood Partners Reduce 21.28% 240,931 1.77
Q1  2018
David Rolfe - Wedgewood Partners Reduce 15.48% 207,421 1.33
Lee Ainslie - Maverick Capital Reduce 5.85% 4,650 0.01
Q4  2017
David Rolfe - Wedgewood Partners Reduce 0.24% 3,285 0.01
Q2  2017
David Rolfe - Wedgewood Partners Reduce 24.25% 275,724 1.00
Q1  2017
Lee Ainslie - Maverick Capital Reduce 19.64% 7,550 0.01
Q3  2016
Lee Ainslie - Maverick Capital Reduce 16.72% 5,400 0.01
Q3  2015
Lee Ainslie - Maverick Capital Sell 100.00% 3,920 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.